Profile
ACIU VRTX VRNA REGN ALNY ARGX
Company Name AC Immune S.A. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $359.22M $108.04B $72.68B $68.01B $60.75B $50.28B
Employees 0.13K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Andrea Pfeifer Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
Trading
ACIU VRTX VRNA REGN ALNY ARGX
Last Close $3.84 $417.21 $106.91 $652.91 $481.59 $821.97
High 52 $3.99 $516.74 $106.91 $922.79 $491.09 $849.46
Low 52 $1.48 $366.54 $33.93 $482.92 $224.58 $532.27
Price vs. 52 Week High -3.76 % -19.26 % 0 % -29.25 % -1.93 % -3.24 %
Price vs. 52 Week Low 159.46 % 13.82 % 215.09 % 35.2 % 114.44 % 54.43 %
Total Return
ACIU VRTX VRNA REGN ALNY ARGX
1 Month Return 32.87 % 6.53 % 0.17 % 16.12 % 5.63 % 11.42 %
3 Month Return 76.15 % -11.07 % 1.68 % 17.71 % 41.85 % 37.25 %
6 Month Return 125.22 % -18.11 % 48.2 % 9.05 % 82.89 % 27.56 %
9 Month Return 42.22 % -4.83 % 86.77 % -4.42 % 73.76 % 23.48 %
YTD Return 42.22 % 3.6 % 130.21 % -8.34 % 104.66 % 33.65 %
1 Year Return 29.29 % -12.18 % 212.69 % -29.25 % 71.09 % 48.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.4 % - -
Dividend Paid and Capex Coverage Ration (TTM) -42.88 % 11.09 % -147.93 % 4.25 % -0.43 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Profitability
ACIU VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM 100 % 86.11 % 95.15 % 85.39 % 83.64 % 65.82 %
Return on Assets TTM -26.55 % 15.13 % -14.17 % 11.4 % -6.99 % 15.06 %
Return on Equity TTM -49.04 % 22.14 % -38.66 % 15.31 % -274.21 % 18.96 %
Return on Capital Employed TTM -54.91 % 19.72 % -10.74 % 10.32 % -5.52 % 5.04 %
Net Income Per EBT TTM 100.01 % 83.16 % 111.3 % 88.98 % 84.06 % 237.3 %
EBT Per Ebit TTM 100.8 % 111.48 % 130.22 % 139.5 % 210.66 % 147.38 %
EBIT Per Revenue TTM -173.27 % 34.36 % -25.27 % 25.89 % -7.32 % 13.47 %
Cash Flow To Debt Ratio TTM -866.5 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Receivables Turnover TTM 13.57 6.03 2.55 2.51 4.34 1.91
Payables Turnover TTM 5.31 3.59 3.13 2.3 3.93 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 5.62 2.26
Fixed Asset Turnover TTM 389.94 % 431.08 % 8642.22 % 284.82 % 355.68 % 5009.77 %
Asset Turnover TTM 15.2 % 47.51 % 38.7 % 35.47 % 53.92 % 31.97 %
Operating Cash Flow Per Share TTM -0.42 14.98 -0.85 48.94 -0.12 5.67
Free Cash Flow Per Share TTM -0.43 13.63 -0.85 40.09 -0.4 5.58
Cash Per Share TTM 126.34 % 2486.48 % 511.44 % 8148.65 % 2203.63 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -147.39 % 33.68 % -32.7 % 35.59 % -0.63 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.33 % 90.99 % 100.75 % 81.92 % 335.21 % 98.47 %
Cash Flow Coverage Ratios TTM -866.5 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Price To Free Cash Flows Ratio TTM -6.54 30.87 -995.27 16.37 -1166.22 132.81
Price To Operating Cash Flows Ratio TTM -6.73 28.12 -126.33 13.34 -3867.41 151.69
Price Cash Flow Ratio TTM -6.73 28.12 -126.33 13.34 -3867.41 151.69
Income Statement (TTM)
ACIU VRTX VRNA REGN ALNY ARGX
Revenue $0.03B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0.03B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.05B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.05B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -0.51 -2.08 -1.73 38.34 -2.16 12.78
Balance Sheet (MRQ)
ACIU VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0.12B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $0.11B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0.13B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0.01B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $0.23B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
ACIU VRTX VRNA REGN ALNY ARGX
Net Income $-0.05B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 32.9
AARD Aardvark Therapeutics, Inc. Common Stock 11.38
ABCL AbCellera Biologics Inc. 5.57
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.07
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.26
ABPWW 0.0142
ABSI Absci Corporation 4.29
ABUS Arbutus Biopharma Corporation 4.69
ABVC ABVC BioPharma, Inc. 2.855
ABVX Abivax SA American Depositary Shares 103.151
ACAD ACADIA Pharmaceuticals Inc. 22.6088
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7838
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.91
ACLX Arcellx, Inc. 85.78
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01828 157.93
GWX SPDR S&P International Small Cap ETF 0.02 39.93
BIB ProShares Ultra Nasdaq Biotechnology 0.0202553 70.09
SBIO ALPS Medical Breakthroughs ETF 0.002 44.8
BMED BlackRock Future Health ETF 0.0106 28.425
IBBQ Invesco Nasdaq Biotechnology ETF 0.029 26.38
DFAT Dimensional U.S. Targeted Value ETF 0.0001165 57.265
DFAS Dimensional U.S. Small Cap ETF 0.00026091 68.4
DFAC Dimensional U.S. Core Equity 2 ETF 0.00007154 39.205
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02832 6.662
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02832 7.7275
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0312 47.6
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02832 7.599
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0312 54.16
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 35.27
DFSU Dimensional US Sustainability Core 1 ETF 0.00026094 43.31
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02832 5.8635
DXUV Dimensional ETF Trust 0.00002414 58.75
Unlock